➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Mallinckrodt
Harvard Business School
Colorcon
Express Scripts

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Cmp-2-Keto-3-Deoxy-Octulosonic Acid


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Cmp-2-Keto-3-Deoxy-Octulosonic Acid?

Cmp-2-Keto-3-Deoxy-Octulosonic Acid is an investigational drug.

There have been 7 clinical trials for Cmp-2-Keto-3-Deoxy-Octulosonic Acid. The most recent clinical trial was a Phase 2 trial, which was initiated on September 11th 2018.

The most common disease conditions in clinical trials are Carcinoma, Liver Failure, and Leukemia, Lymphoid. The leading clinical trial sponsors are National Cancer Institute (NCI), Le Bonheur Children's Hospital, and Mayo Clinic.

There are six US patents protecting this investigational drug and one hundred and seventeen international patents.

Recent Clinical Trials for Cmp-2-Keto-3-Deoxy-Octulosonic Acid
TitleSponsorPhase
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except MelanomaNational Cancer Institute (NCI)Phase 1/Phase 2
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except MelanomaUniversity of Southern CaliforniaPhase 1/Phase 2
Branched-chain Amino Acid Supplementation for Hepatocellular CarcinomaUniversity Medical Center-New OrleansPhase 2

See all Cmp-2-Keto-3-Deoxy-Octulosonic Acid clinical trials

Clinical Trial Summary for Cmp-2-Keto-3-Deoxy-Octulosonic Acid

Top disease conditions for Cmp-2-Keto-3-Deoxy-Octulosonic Acid
Top clinical trial sponsors for Cmp-2-Keto-3-Deoxy-Octulosonic Acid

See all Cmp-2-Keto-3-Deoxy-Octulosonic Acid clinical trials

US Patents for Cmp-2-Keto-3-Deoxy-Octulosonic Acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cmp-2-Keto-3-Deoxy-Octulosonic Acid ⤷  Free Forever Trial Mannitol induced promoter systems in bacterial host cells Dow Global Technologies Inc. (Midland, MI) ⤷  Free Forever Trial
Cmp-2-Keto-3-Deoxy-Octulosonic Acid ⤷  Free Forever Trial Methods and systems to identify operational reaction pathways The Regents of the University of California (Oakland, CA) ⤷  Free Forever Trial
Cmp-2-Keto-3-Deoxy-Octulosonic Acid ⤷  Free Forever Trial Protein expression systems Pfenex, Inc (San Diego, CA) ⤷  Free Forever Trial
Cmp-2-Keto-3-Deoxy-Octulosonic Acid ⤷  Free Forever Trial Method for screening essential metabolites in growth of microorganisms Korea Advanced Institute of Science and Technology (Daejeon, KR) ⤷  Free Forever Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cmp-2-Keto-3-Deoxy-Octulosonic Acid

Drugname Country Document Number Estimated Expiration Related US Patent
Cmp-2-Keto-3-Deoxy-Octulosonic Acid Australia AU2013371454 2033-01-02 ⤷  Free Forever Trial
Cmp-2-Keto-3-Deoxy-Octulosonic Acid Brazil BR112015015832 2033-01-02 ⤷  Free Forever Trial
Cmp-2-Keto-3-Deoxy-Octulosonic Acid Canada CA2896858 2033-01-02 ⤷  Free Forever Trial
Cmp-2-Keto-3-Deoxy-Octulosonic Acid China CN104884073 2033-01-02 ⤷  Free Forever Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
McKinsey
Colorcon
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.